Summary
This 2024 multicentre international study describes the development of the TRIVALVE Score, a risk stratification tool designed to improve patient selection and outcome prediction for transcatheter mitral valve interventions. The tool integrates clinical, anatomical and procedural variables to support clinical decision-making in this emerging cardiac intervention domain. The work represents a collaborative effort to formalise risk assessment in an increasingly common interventional procedure.
Regional applicability
The TRIVALVE Score may be applicable to UK interventional cardiology practice, particularly in tertiary cardiac centres performing transcatheter mitral valve procedures. However, validation in United Kingdom-specific populations and healthcare settings would be necessary to establish local utility and inform NICE guidance on patient selection.
Key measures
TRIVALVE Score components (clinical, anatomical and procedural variables); patient outcome prediction; risk stratification categories
Outcomes reported
The study reports development and validation of the TRIVALVE Score, a risk stratification tool that integrates clinical, anatomical and procedural variables to predict outcomes in patients undergoing transcatheter mitral valve interventions.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.